Concepedia

Publication | Open Access

Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study

54

Citations

28

References

2024

Year

Abstract

Financial support for the registry from Biogen, Novartis and Roche.

References

YearCitations

Page 1